malaria tertiana (Plasmodium vivax / ovale)
Advices
Priority | Medication | Remarks |
---|---|---|
Priority: 1st choice |
Medication: chloroquine po 600mg 1dd 2 days followed by
chloroquine po 300mg one-off |
Remarks:
Cave: chloroquine resistente P. vivax ZO-Azië |
Priority: 2nd choice |
Medication: artemether/lumefantrine po 80/480mg dd |
Remarks:
dosis (=4 tabletten a 20/120mg) op t=0, 8, 24, 36, 48 en 60 uur. 1e keuze bij chloroquine resistente P. vivax uit ZO Azie. |
Priority: 2nd choice alternative |
Medication: atovaquon+proguanil po 1000/400mg 1dd 3 days |
Remarks:
dosis = 4 tabletten a 250/100mg |
Priority | Medication | Remarks |
---|---|---|
Priority: 1st choice |
Medication: chloroquine po 600mg 1dd 2 days followed by
chloroquine po 300mg one-off |
Remarks:
Cave: chloroquine resistente P. vivax ZO-Azië |
Priority: 2nd choice |
Medication: artemether/lumefantrine po 80/480mg dd |
Remarks:
dosis (4 tabletten a 20/120mg) op t=0, 8, 24, 36, 48 en 60 uur. 1e keuze bij chloroquine resistente P. vivax uit ZO Azie. |
Priority: 3rd choice |
Medication: quinine po 600mg 3dd 7 days +
clindamycine po 5mg/kg 3dd 7 days |
Priority | Medication | Remarks |
---|---|---|
Medication: primaquine po 30mg 1dd 14 days |
Remarks:
= nabehandeling (voorkomt recidief) |
Sources
-
https://reliefweb.int/report/world/who-guidelines-malaria-25-november-2022
WHO guideline for the treatment of malaria
Antimicrobial resources
The following antimicrobial agents have been used in these recommendations:
- chloroquine
- atovaquon+proguanil
- artemether/lumefantrine
- quinine
- clindamycine
- primaquine
External antimicrobial resources
Menu position
Metadata
Swab vid: G-147880.8
Updated: 12/29/2023 - 12:10
Status: Published
General comments
Behandeling malaria altijd in overleg met consulent tropenziekten.
Bij zeer ernstige presentatie, overweeg behandelen als ernstige malaria tropica.
Resistente P. vivax in ZO-Azië
Chloroquine:
Artemether/lumefantrine
Atovaquone /proguanil:
Primaquine
Meldingsplichtige ziekte groep C